|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-8
|
|
pubmed:abstractText |
For patients on T(4) replacement, the dose is guided by serum TSH concentrations, but some patients request higher doses due to adverse symptoms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1945-7197
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
186-93
|
|
pubmed:meshHeading |
pubmed-meshheading:19906785-Adolescent,
pubmed-meshheading:19906785-Adult,
pubmed-meshheading:19906785-Aged,
pubmed-meshheading:19906785-Aged, 80 and over,
pubmed-meshheading:19906785-Cardiovascular Diseases,
pubmed-meshheading:19906785-Comorbidity,
pubmed-meshheading:19906785-Female,
pubmed-meshheading:19906785-Fractures, Bone,
pubmed-meshheading:19906785-Hormone Replacement Therapy,
pubmed-meshheading:19906785-Humans,
pubmed-meshheading:19906785-Hypothyroidism,
pubmed-meshheading:19906785-Male,
pubmed-meshheading:19906785-Middle Aged,
pubmed-meshheading:19906785-Osmolar Concentration,
pubmed-meshheading:19906785-Osteoporosis,
pubmed-meshheading:19906785-Thyrotropin,
pubmed-meshheading:19906785-Thyroxine,
pubmed-meshheading:19906785-Time Factors,
pubmed-meshheading:19906785-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy.
|
|
pubmed:affiliation |
Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
